| Product NDC: | 23155-170 |
| Proprietary Name: | Zoledronic acid |
| Non Proprietary Name: | Zoledronic acid |
| Active Ingredient(s): | 4 mg/5mL & nbsp; Zoledronic acid |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 23155-170 |
| Labeler Name: | Heritage Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA201783 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121220 |
| Package NDC: | 23155-170-31 |
| Package Description: | 1 VIAL, GLASS in 1 CARTON (23155-170-31) > 5 mL in 1 VIAL, GLASS |
| NDC Code | 23155-170-31 |
| Proprietary Name | Zoledronic acid |
| Package Description | 1 VIAL, GLASS in 1 CARTON (23155-170-31) > 5 mL in 1 VIAL, GLASS |
| Product NDC | 23155-170 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Zoledronic acid |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20121220 |
| Marketing Category Name | ANDA |
| Labeler Name | Heritage Pharmaceuticals Inc. |
| Substance Name | ZOLEDRONIC ACID |
| Strength Number | 4 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |